Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Hormone Receptor Positive Malignant Neoplasm of Breast|Metastatic Breast Cancer
Interventions: DRUG: Everolimus plus Exemestane
Sponsor: Amsterdam UMC, location VUmc
Collaborators: Borstkanker Onderzoek Groep|Novartis